MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.
复制标题
DOI:
10.12659/msm.895562
复制
发表时间:
2015-10-19
期刊:
影响因子:
--
通讯作者:
Wang X
中科院分区:
文献类型:
--
作者:
Liu X;Ma L;Rao Q;Mao Y;Xin Y;Xu H;Li C;Wang X
Ovarian cancer is the most lethal gynecological malignant cancer in the female genital system. The dysfunction of miRNA contributes to ovarian cancer development. The miR-1271 level in ovarian cancer tissues and cells was assayed by qRT-PCR. The miR-1271 expression in cells was overexpressed by miRNA-mimic transfection and reduced by miRNA-antisense-oligonucleotide (ASO) transfection. Cell proliferation was analyzed by an MTT assay. The targeted genes were predicted by a bioinformatics algorithm and confirmed by a dual luciferase reporter assay. The protein level was assayed by Western blotting. The ovarian cancer tissue and cell lines showed low levels of miR-1271. Low levels of miR-1271 in ovarian cancer tissues were correlated with a low rate of patient survival, and the overexpression of miR-1271 inhibited the proliferation of ovarian cancer cells. The 3′ UTR of cyclin G1 (CCNG1) was targeted by miR-1271. Low levels of miR-1271 in ovarian cancer tissues promoted cancer cell growth. MiR-1271 may be a new predictor of prognosis in ovarian cancer. MiR-1271 exerted its role by targeting CCNG1.